Prescription Drugs

WASHINGTON, D.C. – In a Senate Judiciary Committee hearing today, U.S. Senator Peter Welch (D-Vt.) pressed Pharmacy Benefit Managers (PBMs) on how their anti-competitive practices have raised costs for Vermont patients by undermining competition in the prescription drug supply chain. Senator Welch also discussed how…
A bipartisan pair of senators introduced legislation to lower prescription drug prices by prohibiting pharmaceutical companies from selling drugs in the U.S. at higher prices than the international average.  The bill from Sens. Josh Hawley (R-Mo.) and Peter Welch (D-Vt.) is a riff on the “most favored nation” policy…
WASHINGTON, D.C. – U.S. Senator Peter Welch (D-Vt.), a member of the Senate Finance Committee, this week took to the Senate Floor to highlight the Senate Finance Committee’s new report that found Pfizer, which generated $20 billion in U.S. sales of prescription drugs in 2019,…
  • 1
  • 2